Turning to Thyroid Disease in Pregnant Women

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Standard

Turning to Thyroid Disease in Pregnant Women. / Andersen, Stine Linding; Andersen, Stig.

I: European Thyroid Journal, Bind 9, Nr. 5, 09.2020, s. 225-233.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Harvard

Andersen, SL & Andersen, S 2020, 'Turning to Thyroid Disease in Pregnant Women', European Thyroid Journal, bind 9, nr. 5, s. 225-233. https://doi.org/10.1159/000506228

APA

Andersen, S. L., & Andersen, S. (2020). Turning to Thyroid Disease in Pregnant Women. European Thyroid Journal, 9(5), 225-233. https://doi.org/10.1159/000506228

CBE

Andersen SL, Andersen S. 2020. Turning to Thyroid Disease in Pregnant Women. European Thyroid Journal. 9(5):225-233. https://doi.org/10.1159/000506228

MLA

Andersen, Stine Linding og Stig Andersen. "Turning to Thyroid Disease in Pregnant Women". European Thyroid Journal. 2020, 9(5). 225-233. https://doi.org/10.1159/000506228

Vancouver

Andersen SL, Andersen S. Turning to Thyroid Disease in Pregnant Women. European Thyroid Journal. 2020 sep;9(5):225-233. https://doi.org/10.1159/000506228

Author

Andersen, Stine Linding ; Andersen, Stig. / Turning to Thyroid Disease in Pregnant Women. I: European Thyroid Journal. 2020 ; Bind 9, Nr. 5. s. 225-233.

Bibtex

@article{2b33c15db0c740a896feb44377ff24a0,
title = "Turning to Thyroid Disease in Pregnant Women",
abstract = "Thyroid disease in pregnant women needs attention from a clinical and scientific standpoint due to the potential severe adverse consequences. It is well-established that overt thyroid disease in pregnant women should be treated to prevent maternal and fetal complications, but routine testing for overt thyroid function test abnormalities has not been implemented. In contrast, the scientific focus has shifted towards smaller aberrations in maternal thyroid function including subclinical thyroid disease and isolated deviations in maternal thyroxine. In this focused review, we touch upon the assessment of maternal thyroid function in pregnancy and how the historical advancements in thyroid function tests parallel with the thyroid function test abnormalities described. Furthermore, we discuss how the scientific focus has evolved and how the field could turn in view of the existing discrepancies between results of observational studies and randomized controlled trials. ",
author = "Andersen, {Stine Linding} and Stig Andersen",
year = "2020",
month = sep,
doi = "10.1159/000506228",
language = "English",
volume = "9",
pages = "225--233",
journal = "European Thyroid Journal",
issn = "2235-0640",
publisher = "S. Karger AG",
number = "5",

}

RIS

TY - JOUR

T1 - Turning to Thyroid Disease in Pregnant Women

AU - Andersen, Stine Linding

AU - Andersen, Stig

PY - 2020/9

Y1 - 2020/9

N2 - Thyroid disease in pregnant women needs attention from a clinical and scientific standpoint due to the potential severe adverse consequences. It is well-established that overt thyroid disease in pregnant women should be treated to prevent maternal and fetal complications, but routine testing for overt thyroid function test abnormalities has not been implemented. In contrast, the scientific focus has shifted towards smaller aberrations in maternal thyroid function including subclinical thyroid disease and isolated deviations in maternal thyroxine. In this focused review, we touch upon the assessment of maternal thyroid function in pregnancy and how the historical advancements in thyroid function tests parallel with the thyroid function test abnormalities described. Furthermore, we discuss how the scientific focus has evolved and how the field could turn in view of the existing discrepancies between results of observational studies and randomized controlled trials.

AB - Thyroid disease in pregnant women needs attention from a clinical and scientific standpoint due to the potential severe adverse consequences. It is well-established that overt thyroid disease in pregnant women should be treated to prevent maternal and fetal complications, but routine testing for overt thyroid function test abnormalities has not been implemented. In contrast, the scientific focus has shifted towards smaller aberrations in maternal thyroid function including subclinical thyroid disease and isolated deviations in maternal thyroxine. In this focused review, we touch upon the assessment of maternal thyroid function in pregnancy and how the historical advancements in thyroid function tests parallel with the thyroid function test abnormalities described. Furthermore, we discuss how the scientific focus has evolved and how the field could turn in view of the existing discrepancies between results of observational studies and randomized controlled trials.

UR - http://www.scopus.com/inward/record.url?scp=85082526667&partnerID=8YFLogxK

U2 - 10.1159/000506228

DO - 10.1159/000506228

M3 - Review

C2 - 33088790

AN - SCOPUS:85082526667

VL - 9

SP - 225

EP - 233

JO - European Thyroid Journal

JF - European Thyroid Journal

SN - 2235-0640

IS - 5

ER -